← All trials
NCT05373147
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 30, 2020
- Primary completion
- Feb 28, 2023
- Completion date
- Aug 31, 2023
- First posted
- May 13, 2022
- Last posted
- Oct 26, 2022
- Enrollment
- 21
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai UniversityLead sponsor
- Shanghai UniversityReponsible party - principal investigator
- Shanghai Cell Therapy Group Co.,LtdCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.